Search by Drug Name or NDC
NDC 71981-0020-07 OXERVATE 20 ug/mL Details
OXERVATE 20 ug/mL
OXERVATE is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Domp. The primary component is CENEGERMIN.
MedlinePlus Drug Summary
Ophthalmic cenegermin-bkbj is used to treat neurotrophic keratitis (a degenerative eye disease that can lead to damage of the cornea [the outermost layer of the eye]). Cenegermin-bkbj is in a class of medications called recombinant human nerve growth factors. It works to heal the cornea.
Related Packages: 71981-0020-07Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cenegermin-bkbj Ophthalmic
Product Information
| NDC | 71981-0020 |
|---|---|
| Product ID | 71981-020_39e193f0-1484-49f9-b162-c64f0a8cb158 |
| Associated GPIs | 86770020202020 |
| GCN Sequence Number | 079287 |
| GCN Sequence Number Description | cenegermin-bkbj DROPS 0.002 % OPHTHALMIC |
| HIC3 | Q2S |
| HIC3 Description | OPHTHALMIC HUMAN NERVE GROWTH FACTOR (HNGF) |
| GCN | 45762 |
| HICL Sequence Number | 045258 |
| HICL Sequence Number Description | CENEGERMIN-BKBJ |
| Brand/Generic | Brand |
| Proprietary Name | OXERVATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | cenegermin-bkbj |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | ug/mL |
| Substance Name | CENEGERMIN |
| Labeler Name | Domp |
| Pharmaceutical Class | Nerve Growth Factor [CS], Recombinant Human Nerve Growth Factor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761094 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71981-0020-07 (71981002007)
| NDC Package Code | 71981-020-07 |
|---|---|
| Billing NDC | 71981002007 |
| Package | 7 VIAL, MULTI-DOSE in 1 CARTON (71981-020-07) / 1 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2018-11-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |